Immune Response News and Research

RSS

Chlamydia vaccine shows promise after a successful clinical trial

A vaccine against the sexually transmitted infection (STI) chlamydia is now a substantial step closer to reality after successfully passing its Phase 1 clinical trial.

14 Aug 2019

Researchers identify molecular switch that impacts immune responses to viral infections

Walter and Eliza Hall Institute researchers have identified a molecular switch that impacts immune responses to viral infections, and whether or not protective antibodies are produced.

14 Aug 2019

Researchers make scientific breakthrough regarding Leishmania virulence strategy

A team from the Institut National de la Recherche Scientifique has made a scientific breakthrough regarding the virulence strategy employed by the Leishmania parasite to infect cells of the immune system.

12 Aug 2019

New T cell detection method promises personalized immunotherapy for melanomas

An important new study shows that better T cell detection is now possible using revolutionary technology. T cells are a type of lymphocyte, which in turn belongs to the diverse family of immune cells. They take part in cancer fighting as well as in most other immune responses.

12 Aug 2019

Antibody may help the immune system fight sepsis-related fungal infections

An antibody that blocks the "programmed cell death" pathway may help the immune system fight off sepsis-related fungal infections, according to animal studies reported in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.

12 Aug 2019

NIH-funded clinical trial will evaluate seasonal influenza vaccines with two experimental adjuvants

An early-stage clinical trial is evaluating two licensed seasonal influenza vaccines, administered with or without novel adjuvants, for their safety and ability to generate an immune response.

9 Aug 2019

Study reveals Lassa virus' soft spot

As this year's Lassa fever outbreak in Nigeria is finally ebbing, the total tally came to more than 600 infected people, one-quarter of them dead. Thousands more die each year, uncounted in rural villages throughout West Africa.

9 Aug 2019

New technology uses immune system to deliver drugs directly to infection sites

A researcher at Washington State University Health Sciences Spokane has developed a new technology that harnesses the immune system to deliver drugs directly to infection sites within the body.

9 Aug 2019

Existing FDA-approved drug could potentially help contain Ebola infection

Amid the worsening Ebola outbreak in the Congo, now threatening to spill into Rwanda, a new study suggests that an existing, FDA-approved drug called nitazoxanide could potentially help contain this deadly, highly contagious infection.

8 Aug 2019

Moffitt study uncovers subtypes of squamous cell lung cancer

Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types.

8 Aug 2019

Exposure to C. Difficile in infancy produces immunity against gastrointestinal infection

Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal

7 Aug 2019

New nanovaccine for deadly skin cancer

Tel Aviv scientists have published their version of a vaccine against the deadly skin cancer malignant melanoma, which arises from the pigment producing cells of the skin. This is the most feared form of skin cancer, with a high tendency to metastasize to distant parts of the body, including the brain.

6 Aug 2019

Discovery of unusual HBV in shrews offers new opportunity to better understand the disease

The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate that an important protein which is essential for the development of a chronic course of infection is not present in this virus.

3 Aug 2019

Edinburgh has highest known rates of inflammatory bowel disease

Edinburgh has some of the highest known rates of inflammatory bowel disease in the world and the figure is expected to rise in the next 10 years.

2 Aug 2019

New drug combination successfully reduces levels of bovine leukemia virus

Scientists have succeeded in reducing levels of the bovine leukemia virus in cows with severe infections by combining an immune checkpoint inhibitor and an enzyme inhibitor.

2 Aug 2019

Congo’s Ebola outbreak continues rampant

It was a year ago that the Ebola virus outbreak in the Congo became official. And far from subsiding, just two weeks ago it became “a public health emergency of international concern”. More than 2,600 cases have been confirmed and over 1,800 deaths in the affected provinces of the Democratic Republic of the Congo. A third of these are children.

1 Aug 2019

Psychological stress linked to higher risk of cancer-specific mortality in cervical cancer patients

Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

1 Aug 2019

Researchers discover SIGN-R1 molecule that recognizes multiple variants of influenza

A team of researchers from the Institute for Research in Biomedicine (IRB, affiliated to USI Università della Svizzera italiana, Switzerland) have discovered and identified a molecule - SIGN-R1 - capable of recognizing the multiple variants of influenza and consequently 'directing' the immune response in individuals affected by the disease.

30 Jul 2019

Gut bacteria that prevents mice from becoming obese may also control weight in people

Researchers at University of Utah Health have identified a specific class of bacteria from the gut that prevents mice from becoming obese, suggesting these same microbes may similarly control weight in people.

26 Jul 2019

Researchers demonstrate positive and negative role of LRH-1 during inflammation

Immune cells prevent bacteria, parasites or viruses from entering the body when, for example, the intestinal epithelium is injured.

26 Jul 2019

Immune Response News and Research

Chlamydia vaccine shows promise after a successful clinical trial

Researchers identify molecular switch that impacts immune responses to viral infections

Researchers make scientific breakthrough regarding Leishmania virulence strategy

New T cell detection method promises personalized immunotherapy for melanomas

Antibody may help the immune system fight sepsis-related fungal infections

NIH-funded clinical trial will evaluate seasonal influenza vaccines with two experimental adjuvants

Study reveals Lassa virus' soft spot

New technology uses immune system to deliver drugs directly to infection sites

Existing FDA-approved drug could potentially help contain Ebola infection

Moffitt study uncovers subtypes of squamous cell lung cancer

Exposure to C. Difficile in infancy produces immunity against gastrointestinal infection

New nanovaccine for deadly skin cancer

Discovery of unusual HBV in shrews offers new opportunity to better understand the disease

Edinburgh has highest known rates of inflammatory bowel disease

New drug combination successfully reduces levels of bovine leukemia virus

Congo’s Ebola outbreak continues rampant

Psychological stress linked to higher risk of cancer-specific mortality in cervical cancer patients

Researchers discover SIGN-R1 molecule that recognizes multiple variants of influenza

Gut bacteria that prevents mice from becoming obese may also control weight in people

Researchers demonstrate positive and negative role of LRH-1 during inflammation

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News